|
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial) investigator-initiated grant from Becton, Dickinson and Company |
|
|
Comparative effectiveness of interventions to prevent bloodstream infections in central venous catheters: The IVCare adaptive platform trial (IVCare) National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451) |
|
|
Subcutaneously anchored securement system versus a traditional sutureless securement device for prevention of Peripherally Inserted Central Catheter dislodgement: a randomised controlled trial Darling Downs Health Hospital Foundation Grant |
|
|
Characterisation of Intravascular Access Device (IVAD) Staphylococcus aureus Blood Stream Infection (SAB) |
|
|
Reducing blood culture contamination with the use of a needleless blood draw device (PIVO Pro): An adaptive group sequential randomized controlled trial (the PIVO trial) Becton, Dickinson and Company; Herston Infectious Diseased Institute (HeIDI) |
|
|
Comparative effectiveness of Class II/III medical devices to prevent bloodstream infections in central venous access devices: The IVCare adaptive platform trial (IVCare) National Health and Medical Research Council (NHMRC) Investigator grant (Award ID: 2016399) and Medical Research Future Fund (MRFF) 2023 Clinical Trials Activity grant (Award ID: 2035451) |
|
|
Mortality, length of stay, and cost attributable to CRBSI and CLABSI in patients with a central venous catheter in an Australian tertiary hospital: a case-control study |
|
|
Health care associated infection burden in Queensland, Australia Queensland Government |
|
|
Translating Healthcare-Associated Infection Prevention Research into Practice: Australian Hospitals Survey 2025 |
|
